UNSPSC 85701303: Revision of autologous tissue substitute in left acetabulum, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in left acetabulum, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0QW537Z

UNSPSC 85701303, Revision of autologous tissue substitute in left acetabulum, percutaneous approach, is a Commodity code that does not reflect the scope of work being solicited under this code in recent state and local procurement activity. The three recent opportunities tagged to this code involve independent medical evaluations for disability pension determinations, occupational medical surveillance, specialty surgical benefit management, and temporary health professional staffing—none of which align with orthopedic surgical revision procedures. The code shows minimal relevant recent activity, and the mismatch between the code's nominal clinical scope and the actual procurements suggests either persistent misclassification in the source data or exceptionally sparse activity under the intended commodity definition.

The six opportunities in the source block span medical services broadly—including disability evaluations by the City of Phoenix Retirement Office (RFP due October 16, 2026), occupational medical surveillance by the Washington State Department of Transportation on behalf of Washington State Ferries (RFP due October 9, 2026), surgical benefit carve-out services by the City of Long Beach (RFP due October 7, 2026), pharmacy benefit management by Collier County Board of County Commissioners (RFP due April 9, 2026), emergency and specialty medical services for detained youth by Harris County Juvenile Probation Department (RFI due September 25, 2026), and temporary health professional staffing by the County of Santa Clara Health System (RFP due October 7, 2026). Issuing bodies include state departments, county health systems, city retirement offices, and county human services agencies. Geographic activity centers on Washington, Arizona, California, Florida, and Texas. Given the absence of procurement activity directly related to autologous tissue substitute revisions, firms evaluating this code should treat it as inactive for state and local opportunity development.